The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-lasting ...

Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...

I paired my Oura ring with Dexcom's Stelo AI-powered CGM to track my glucose. Here's what I learned about my eating habits.

Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like ...

For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon-like peptide ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...

CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...

CHICAGO — Actor, comedian and diabetes advocate Anthony Anderson has lived with diabetes for almost 25 years, and has made ...

BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene ...

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

MannKind Corporation (NASDAQ:MNKD) aims to release the topline results from the full pediatric study with safety extension in ...